Guardian Pharmacy Services Full Year 2024 Earnings: EPS Misses Expectations
Truist Financial Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $24
Raymond James Initiates Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $25
Analysts Offer Insights on Healthcare Companies: Clene (CLNN), Perspective Therapeutics (CATX) and Guardian Pharmacy Services, Inc. Class A (GRDN)
Q4 2024 Guardian Pharmacy Services Inc Earnings Call
Guardian Pharmacy Services Reports Strong Revenue Growth
GUARDIAN PHARMACY SERVICES Earnings Results: $GRDN Reports Quarterly Earnings
Guardian Pharmacy Services | 10-K: FY2024 Annual Report
Guardian Pharmacy Services | 8-K: Guardian Pharmacy Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Express News | Guardian Pharmacy Services Inc Outlook FY25 Revenue of $1.330 Bln to $1.350 Bln
Guardian Pharmacy Svcs 4Q Rev $338.6M >GRDN
Guardian Pharmacy Svcs 4Q EPS 19c >GRDN
Press Release: Guardian Pharmacy Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Are Investors Undervaluing Guardian Pharmacy Services, Inc. (NYSE:GRDN) By 31%?
Earnings Scheduled For March 26, 2025
IPO Roundup: CoreWeave, StubHub and More
Earnings Preview: GRDN to Report Financial Results Post-market on March 26
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Truist Financial Sticks to Their Buy Rating for Guardian Pharmacy Services, Inc. Class A (GRDN)
Guardian Pharmacy Services | 8-K: Guardian Pharmacy Services, Inc. Announces Preliminary Fourth Quarter and Full Year 2024 Results; Provides 2025 Financial Guidance and Earnings Conference Call Date